Distinguished in Intestinal Pseudo-Obstruction

Hirokazu Takahashi

Saga, JP 
Distinguished in Intestinal Pseudo-Obstruction
Saga, JP 
OverviewLocationsClinical Research

Overview

Hirokazu Takahashi practices in Saga, Japan. Takahashi is rated as a Distinguished expert by MediFind in the treatment of Intestinal Pseudo-Obstruction. Their top areas of expertise are Non-Alcoholic Fatty Liver Disease, Cirrhosis, Hepatitis, Endoscopy, and Colonoscopy.

Their clinical research consists of co-authoring 455 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Intestinal Pseudo-Obstruction.

Locations

Saga, Japan
Other Locations
Nabeshima, 8498501, Japan
Tokyo, Japan
Nagoya, Japan
Ikoma, 6300192, Japan
Hiroshima, 7398530, Japan
Okayama, 7008530, Japan
Chuo, 1040045, Japan
Gifu-shi, Japan
Hongo, 1138656, Japan
Sendai, Japan
Higashihiroshima, 7398530, Japan
Eguchi, Japan
Nabeshima, Japan
Meguro, 1538904, Japan
CREST, Sanbancho 5, Chiyoda, 1020075, Japan
Uji, Japan
Toyota, Japan
Yokohama, 2360004, Japan
Japan
Kawaguchi, Japan
Furo Cho, Nagoya 464-8601, Japan, Biotechnology Center Borj Cedria Science And Technology Park, Route Touristique Borj Cedria Soliman, BP 901, 2050 Hammam Lif, 1-1-1 Yayoi, Bunkyo Ku, Tokyo 113-8657, 1-308 Suematsu, Nonoichi, 9218836, Japan
Tsukuba, Japan
Komaba, 1538904, Japan
Yayoi, 1138657, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2

455 Total Publications

Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries.
Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Takahashi's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 45 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile